EHMTI-0087. Use of oxicodone/naloxone extended release for menstrual migraine [PDF]
, 2014 C. Mostardini, Giovanni M. Pauletti
openalex +1 more source
When Should Naloxone Be Administered to the Undifferentiated Unresponsive Person?
, 2018 Ira Nemeth +2 more
openalex +2 more sources
Development of a Low-Barrier, Reimbursable Take-Home Naloxone Program at a Regional Health System. [PDF]
West J Emerg MedLondon KS +10 more
europepmc +1 more source
Practical guidance for navigating buprenorphine discontinuation. [PDF]
Harm Reduct JSonoda K, Hilmer AB, Bello JK.
europepmc +1 more source
Substance use treatment and overdose patterns in high and low social vulnerability counties: a trends analysis in New Jersey from 2014-2022. [PDF]
Addict Behav RepCooper SE +5 more
europepmc +1 more source
Efficacy and safety of opioid-receptor antagonists for opioid-induced constipation: a systematic review and meta-analysis. [PDF]
Front PharmacolLi Y +9 more
europepmc +1 more source
Effect of five common anticonvulsant drugs on naloxone-precipitated morphine withdrawal in mice.
, 2011 Valiollah Hajhashemi, M Abed-Natanzi
openalex +1 more source
Effects of Naloxone and Naltrexone on Receptive and Proceptive Behaviors in Female Rats
, 1992 Tôru Saitô +6 more
openalex +2 more sources